Abbott Laboratories ( ABT) - Stock Earnings
ABT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.8 billion USD | 11.5 billion USD |
| 2026Q1 | 1.1 billion USD | 11.2 billion USD |
| 2026Q2 | 928.0 million USD | 12.6 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ABT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.7 billion USD | 40.1 billion USD |
| 2024 | 13.4 billion USD | 42.0 billion USD |
| 2025 | 6.5 billion USD | 44.3 billion USD |
| 2026 Est. | — | — |
ABT
Price: $116.66
Dividend Yield: 2.36%
Forward Dividend Yield: 2.16%
Payout Ratio: 69.40%
Dividend Per Share: 2.52 USD
Earnings Per Share: 3.12 USD
P/E Ratio: 32.23
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 5.1 million
Ebitda: 1.7 billionMarket Capitalization: 181.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 44
DGR3: 7.64%
DGR5: 10.77%
DGR10: 9.57%
DGR20: 8.39%